Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825645 | Clinical Therapeutics | 2012 | 8 Pages |
Abstract
A single 400-mg oral dose of EGCG was safe and well tolerated by all of the patients in the study. These results provide guidance for the continued investigation of the long-term safety and antitumor potential of EGCG in cirrhotic patients with HCV.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dina MD, Walter K. MD, Constantine ScD, Xie PhD, Roy L. PharmD, PhD, Victor J. MD,